Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa

NCT01975441 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

182

Enrollment

OTHER

Sponsor class

Conditions

Lymphatic Filariasis

Interventions

DRUG: Diethylcarbamazine
DRUG: Albendazole
DRUG: Ivermectin

Sponsor

University Hospitals Cleveland Medical Center